Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Delayed Hospital Discharges of Older Patients: A Systematic Review on Prevalence and Costs.

Landeiro F. et al, (2019), Gerontologist, 59, e86 - e97

Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.

Leal J. et al, (2019), Pharmacoeconomics

Decision models of prediabetes populations: a systematic review.

Leal J. et al, (2019), Diabetes Obes Metab

Impact of variation in Type 2 diabetes care on health outcomes and healthcare costs

Keng MJ. et al, (2019), DIABETIC MEDICINE, 36, 161 - 161

Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy.

Leal J. et al, (2018), Eye (Lond)

Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture - A randomised controlled trial and economic evaluation (PROVE trial): ISRCTN 49117867

Barker K. et al, (2018), JOURNAL OF BONE AND MINERAL RESEARCH, 33, 21 - 21

Risk attitudes of people with 'manageable' chronic disease: An analysis under prospect theory.

Rouyard T. et al, (2018), Soc Sci Med, 214, 144 - 153

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)

(2018), Diabetologia

Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL

Reed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial

Becker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366

Repercussion of a national intervention on patient outcomes of primary knee arthroplasty to enhance the recovery pathway: 2008-2016 England trends

Garriga C. et al, (2018)

Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Reed SD. et al, (2018), Diabetes Obes Metab, 20, 1732 - 1739

Nudging people with Type 2 diabetes towards better self-management through personalized risk communication: A pilot randomized controlled trial in primary care.

Rouyard T. et al, (2018), Endocrinol Diabetes Metab, 1

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.

Palmer AJ. et al, (2018), Value Health, 21, 724 - 731

The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.

Leal J. et al, (2018), Pharmacoeconomics

Cost-effectiveness of enhanced recovery in hip and knee replacement: a systematic review protocol.

Murphy J. et al, (2018), BMJ Open, 8

Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study.

Leal J. et al, (2018), Cancer Epidemiol, 52, 99 - 105

Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.

Campbell HE. et al, (2018), BJOG, 125, 108 - 117

Computer simulation models of pre-diabetes populations: a systematic review protocol.

Leal J. et al, (2017), BMJ Open, 7

Costs of fragility hip fractures globally: a systematic review and meta-regression analysis.

Williamson S. et al, (2017), Osteoporos Int, 28, 2791 - 2800

Load More

Include forthcoming?